IL16 and factor V gene variations are associated with asparaginase-related thrombosis in childhood acute lymphoblastic leukemia patients. 2023

Covida Mootoosamy, and Maria Kondyli, and Sophie Annaelle Serfaty, and David-Étienne Tremblay, and Vincent Gagné, and Maïté Ribère, and Caroline Laverdière, and Jean-Marie Leclerc, and Daniel Sinnett, and Thai Hoa Tran, and Maja Krajinovic
Charles-Bruneau Cancer Center, CHU Sainte-Justine Research Center, Montreal, QC, H3T 1C5, Canada.

Aim: We previously conducted exome-wide association study in acute lymphoblastic leukemia patients and identified association of five SNPs with asparaginase-related thrombosis. Here we aimed to replicate these findings in an independent patient cohort and through analyses in vitro. Patients & methods: SNPs located in IL16, MYBBP1A, PKD2L1, RIN3 and MPEG1 genes were analyzed in patients receiving Dana-Farber Cancer Institute acute lymphoblastic leukemia treatment protocols 05-001 and 11-001. Thrombophilia-related variations were also analysed. Results: IL16 rs11556218 conferred higher risk of thrombosis and higher in vitro sensitivity to asparaginase. The association was modulated by the treatment protocol, risk group and immunophenotype. A crosstalk between factor V Leiden, non-O blood groups and higher risk of thrombosis was also seen. Conclusion: IL16 and factor V Leiden variations are implicated in asparaginase-related thrombosis.

UI MeSH Term Description Entries
D011956 Receptors, Cell Surface Cell surface proteins that bind signalling molecules external to the cell with high affinity and convert this extracellular event into one or more intracellular signals that alter the behavior of the target cell (From Alberts, Molecular Biology of the Cell, 2nd ed, pp693-5). Cell surface receptors, unlike enzymes, do not chemically alter their ligands. Cell Surface Receptor,Cell Surface Receptors,Hormone Receptors, Cell Surface,Receptors, Endogenous Substances,Cell Surface Hormone Receptors,Endogenous Substances Receptors,Receptor, Cell Surface,Surface Receptor, Cell
D004268 DNA-Binding Proteins Proteins which bind to DNA. The family includes proteins which bind to both double- and single-stranded DNA and also includes specific DNA binding proteins in serum which can be used as markers for malignant diseases. DNA Helix Destabilizing Proteins,DNA-Binding Protein,Single-Stranded DNA Binding Proteins,DNA Binding Protein,DNA Single-Stranded Binding Protein,SS DNA BP,Single-Stranded DNA-Binding Protein,Binding Protein, DNA,DNA Binding Proteins,DNA Single Stranded Binding Protein,DNA-Binding Protein, Single-Stranded,Protein, DNA-Binding,Single Stranded DNA Binding Protein,Single Stranded DNA Binding Proteins
D005165 Factor V Heat- and storage-labile plasma glycoprotein which accelerates the conversion of prothrombin to thrombin in blood coagulation. Factor V accomplishes this by forming a complex with factor Xa, phospholipid, and calcium (prothrombinase complex). Deficiency of factor V leads to Owren's disease. Coagulation Factor V,Proaccelerin,AC Globulin,Blood Coagulation Factor V,Factor 5,Factor Five,Factor Pi,Factor V, Coagulation
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D001215 Asparaginase A hydrolase enzyme that converts L-asparagine and water to L-aspartate and NH3. EC 3.5.1.1. Asparaginase II,Asparaginase medac,Asparagine Deaminase,Colaspase,Crasnitin,Elspar,Erwinase,Kidrolase,Leunase,Paronal,Deaminase, Asparagine,medac, Asparaginase
D013927 Thrombosis Formation and development of a thrombus or blood clot in BLOOD VESSELS. Atherothrombosis,Thrombus,Blood Clot,Blood Clots,Thromboses
D014157 Transcription Factors Endogenous substances, usually proteins, which are effective in the initiation, stimulation, or termination of the genetic transcription process. Transcription Factor,Factor, Transcription,Factors, Transcription
D015220 Calcium Channels Voltage-dependent cell membrane glycoproteins selectively permeable to calcium ions. They are categorized as L-, T-, N-, P-, Q-, and R-types based on the activation and inactivation kinetics, ion specificity, and sensitivity to drugs and toxins. The L- and T-types are present throughout the cardiovascular and central nervous systems and the N-, P-, Q-, & R-types are located in neuronal tissue. Ion Channels, Calcium,Receptors, Calcium Channel Blocker,Voltage-Dependent Calcium Channel,Calcium Channel,Calcium Channel Antagonist Receptor,Calcium Channel Antagonist Receptors,Calcium Channel Blocker Receptor,Calcium Channel Blocker Receptors,Ion Channel, Calcium,Receptors, Calcium Channel Antagonist,VDCC,Voltage-Dependent Calcium Channels,Calcium Channel, Voltage-Dependent,Calcium Channels, Voltage-Dependent,Calcium Ion Channel,Calcium Ion Channels,Channel, Voltage-Dependent Calcium,Channels, Voltage-Dependent Calcium,Voltage Dependent Calcium Channel,Voltage Dependent Calcium Channels
D016601 RNA-Binding Proteins Proteins that bind to RNA molecules. Included here are RIBONUCLEOPROTEINS and other proteins whose function is to bind specifically to RNA. Double-Stranded RNA-Binding Protein,Double-Stranded RNA-Binding Proteins,ds RNA-Binding Protein,RNA-Binding Protein,ds RNA-Binding Proteins,Double Stranded RNA Binding Protein,Double Stranded RNA Binding Proteins,Protein, Double-Stranded RNA-Binding,Protein, ds RNA-Binding,RNA Binding Protein,RNA Binding Proteins,RNA-Binding Protein, Double-Stranded,RNA-Binding Protein, ds,RNA-Binding Proteins, Double-Stranded,ds RNA Binding Protein

Related Publications

Covida Mootoosamy, and Maria Kondyli, and Sophie Annaelle Serfaty, and David-Étienne Tremblay, and Vincent Gagné, and Maïté Ribère, and Caroline Laverdière, and Jean-Marie Leclerc, and Daniel Sinnett, and Thai Hoa Tran, and Maja Krajinovic
January 2023, Journal of pediatric hematology/oncology,
Covida Mootoosamy, and Maria Kondyli, and Sophie Annaelle Serfaty, and David-Étienne Tremblay, and Vincent Gagné, and Maïté Ribère, and Caroline Laverdière, and Jean-Marie Leclerc, and Daniel Sinnett, and Thai Hoa Tran, and Maja Krajinovic
July 2012, Journal of pharmacology & pharmacotherapeutics,
Covida Mootoosamy, and Maria Kondyli, and Sophie Annaelle Serfaty, and David-Étienne Tremblay, and Vincent Gagné, and Maïté Ribère, and Caroline Laverdière, and Jean-Marie Leclerc, and Daniel Sinnett, and Thai Hoa Tran, and Maja Krajinovic
December 2008, Pediatric blood & cancer,
Covida Mootoosamy, and Maria Kondyli, and Sophie Annaelle Serfaty, and David-Étienne Tremblay, and Vincent Gagné, and Maïté Ribère, and Caroline Laverdière, and Jean-Marie Leclerc, and Daniel Sinnett, and Thai Hoa Tran, and Maja Krajinovic
March 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
Covida Mootoosamy, and Maria Kondyli, and Sophie Annaelle Serfaty, and David-Étienne Tremblay, and Vincent Gagné, and Maïté Ribère, and Caroline Laverdière, and Jean-Marie Leclerc, and Daniel Sinnett, and Thai Hoa Tran, and Maja Krajinovic
January 2015, Leukemia & lymphoma,
Covida Mootoosamy, and Maria Kondyli, and Sophie Annaelle Serfaty, and David-Étienne Tremblay, and Vincent Gagné, and Maïté Ribère, and Caroline Laverdière, and Jean-Marie Leclerc, and Daniel Sinnett, and Thai Hoa Tran, and Maja Krajinovic
December 2004, American journal of hematology,
Covida Mootoosamy, and Maria Kondyli, and Sophie Annaelle Serfaty, and David-Étienne Tremblay, and Vincent Gagné, and Maïté Ribère, and Caroline Laverdière, and Jean-Marie Leclerc, and Daniel Sinnett, and Thai Hoa Tran, and Maja Krajinovic
January 2016, Leukemia & lymphoma,
Covida Mootoosamy, and Maria Kondyli, and Sophie Annaelle Serfaty, and David-Étienne Tremblay, and Vincent Gagné, and Maïté Ribère, and Caroline Laverdière, and Jean-Marie Leclerc, and Daniel Sinnett, and Thai Hoa Tran, and Maja Krajinovic
August 2005, Clinical cancer research : an official journal of the American Association for Cancer Research,
Covida Mootoosamy, and Maria Kondyli, and Sophie Annaelle Serfaty, and David-Étienne Tremblay, and Vincent Gagné, and Maïté Ribère, and Caroline Laverdière, and Jean-Marie Leclerc, and Daniel Sinnett, and Thai Hoa Tran, and Maja Krajinovic
September 2021, Paediatric drugs,
Covida Mootoosamy, and Maria Kondyli, and Sophie Annaelle Serfaty, and David-Étienne Tremblay, and Vincent Gagné, and Maïté Ribère, and Caroline Laverdière, and Jean-Marie Leclerc, and Daniel Sinnett, and Thai Hoa Tran, and Maja Krajinovic
June 1982, The Journal of pediatrics,
Copied contents to your clipboard!